Physician profile
Pedro Hernandez
NPI 1003008327
$399.04
in general payments reported to CMS, 2019-2025
11 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $241 · 2020: $32.30 · 2021: $126.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Johnson and Johnson International | $90.00 | 2019 | |
| Smith+Nephew, INC. | $72.10 | 2019-2020 | |
| Kci USA, INC. | $53.44 | 2019-2021 | |
| Convatec INC. | $38.50 | 2019-2020 | |
| Organogenesis INC. | $31.47 | 2021 | |
| Melinta Therapeutics, LLC | $26.09 | 2019 | |
| Integra Lifesciences Corporation | $23.71 | 2021 | |
| Kerecis Limited | $21.68 | 2021 | |
| Miromatrix Medical INC. | $16.31 | 2019 | |
| Tei Medical INC. | $12.90 | 2019 | |
| Hartmann USA, INC. | $12.84 | 2021 |
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Pedro Hernandez listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.